AQR Capital Management LLC Has $5.01 Million Holdings in Perrigo Company plc (NYSE:PRGO)

AQR Capital Management LLC reduced its holdings in Perrigo Company plc (NYSE:PRGO - Free Report) by 72.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 197,126 shares of the company's stock after selling 522,524 shares during the quarter. AQR Capital Management LLC owned approximately 0.14% of Perrigo worth $5,009,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Franklin Resources Inc. purchased a new position in shares of Perrigo in the third quarter worth about $3,717,000. Barclays PLC boosted its holdings in shares of Perrigo by 44.8% in the third quarter. Barclays PLC now owns 120,502 shares of the company's stock worth $3,160,000 after buying an additional 37,268 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Perrigo by 65.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company's stock worth $14,190,000 after acquiring an additional 213,221 shares during the period. Access Investment Management LLC bought a new stake in Perrigo during the 4th quarter worth approximately $7,989,000. Finally, Charles Schwab Investment Management Inc. raised its stake in Perrigo by 1.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,048,005 shares of the company's stock worth $26,944,000 after acquiring an additional 13,835 shares during the period. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Perrigo Stock Performance

NYSE PRGO traded down $0.31 on Wednesday, reaching $25.91. The stock had a trading volume of 336,546 shares, compared to its average volume of 1,531,496. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo Company plc has a 12-month low of $23.14 and a 12-month high of $31.17. The business's 50-day moving average price is $26.33 and its 200 day moving average price is $26.14. The stock has a market cap of $3.56 billion, a P/E ratio of -22.15 and a beta of 0.45.

Perrigo (NYSE:PRGO - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, beating analysts' consensus estimates of $0.56 by $0.04. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The company had revenue of $1.04 billion during the quarter, compared to analysts' expectations of $1.09 billion. During the same quarter in the previous year, the business earned $0.29 earnings per share. The firm's revenue for the quarter was down 3.5% on a year-over-year basis. As a group, equities analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be paid a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.48%. The ex-dividend date of this dividend is Friday, May 30th. Perrigo's payout ratio is currently -88.55%.

Insider Activity at Perrigo

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares of the company's stock, valued at $923,795.04. The trade was a 18.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.40% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on PRGO shares. Argus cut shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Tuesday, January 14th. StockNews.com lowered shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $33.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.